A telehealth company that built its business around convenient online prescriptions for weight-loss drugs, birth control, and erectile dysfunction medication is now facing something far more serious than a typical regulatory dispute. The Department of Justice has asked a federal court to freeze Zealthy’s assets entirely and place the company into receivership, accusing it of what prosecutors describe as a “runaway campaign of lawbreaking.”
This case has escalated dramatically since it first began, and the company’s own financial survival may now be at stake.
How Zealthy Ended Up in Federal Court
The roots of this case trace back to Kyle Robertson, Zealthy’s founder and CEO, who previously built and led Cerebral, a digital mental health company he founded in 2020. Robertson helped Cerebral raise nearly $500 million in funding and reach a valuation of $4.8 billion before he was removed from the company in May 2022. He founded Zealthy later that same year.
The government’s original lawsuit, filed in 2024, named Cerebral, Robertson, another former Cerebral executive, and the Zealthy-affiliated entities as defendants. Cerebral itself resolved its portion of the case relatively quickly, agreeing to pay roughly $5 million in consumer redress along with a civil penalty judgment, while Zealthy and Robertson continued fighting the underlying allegations.
What the DOJ Actually Alleges
The core accusations against Zealthy center on how the company handled prescriptions. According to court filings, prosecutors allege Zealthy engaged in the systemic ordering of prescriptions by non-clinicians with no prescribing authority, including call center workers based in the Philippines. The complaint goes further, alleging that massive numbers of prescriptions were issued under the names and national provider numbers of licensed medical providers, without those providers’ knowledge or clinical supervision.
In one particularly striking allegation, the company’s own senior medical director reportedly filed a whistleblower complaint claiming Zealthy used his National Provider Identifier and other credentials to submit prior authorizations and medication orders without his knowledge. That’s a serious claim, since it suggests the company may have been generating prescriptions attributed to a real doctor who wasn’t actually reviewing or approving them.
Why the DOJ Wants to Freeze the Company’s Assets
What escalated this case from a standard regulatory dispute into an emergency asset freeze request came from new documents the DOJ obtained during the discovery phase of the original 2024 lawsuit. Based on that additional evidence, prosecutors filed a motion asking the U.S. District Court for the Southern District of Florida to immediately freeze Zealthy’s assets and place the company into receivership.
The government’s reasoning is straightforward but urgent: prosecutors argue Zealthy’s available liquidity may fall short of its total exposure in this litigation, meaning there could be no money left to compensate victims if the company eventually settles or is found liable. A receivership and asset freeze, according to the DOJ’s filing, are necessary specifically to prevent the company from concealing assets or otherwise frustrating any future recovery efforts. Notably, Kyle Robertson himself is named as a defendant, meaning some of his personal assets could also become subject to a court-ordered freeze if the motion is granted.
The Company’s Business Troubles Compounding the Legal Case
Zealthy’s legal problems have already produced real business consequences. In 2025, the company lost its medical merchant certification from LegitScript, a credentialing organization, reportedly for failing to disclose that it was already the target of a federal lawsuit. That loss of certification triggered a cascade of problems: multiple banks and payment processors subsequently dropped Zealthy as a client.
According to the DOJ’s filing, that financial fallout forced Zealthy to form entirely new corporate entities just to continue operating, a detail prosecutors point to as evidence the company was actively restructuring in ways that could complicate any future effort to recover funds on behalf of affected patients.
How Patients Have Reportedly Been Affected
Beyond the prescribing practices allegations, the DOJ’s filing also describes troubling patterns in how Zealthy handled customer accounts and billing. According to the government, the company refused to cancel member accounts even when patients wanted to stop service, effectively forcing some of them to file credit card disputes with their banks just to get refunds processed. Prosecutors have characterized this pattern, combined with the prescribing allegations, as evidence the company was actively deceiving telehealth patients, endangering their safety, and improperly accessing their financial accounts.
What Happens Next
The case now hinges on whether the federal court grants the DOJ’s request for a preliminary injunction freezing Zealthy’s assets and appointing a receiver to oversee the company’s operations and finances. If granted, that would represent a dramatic escalation, essentially placing an outside court-appointed overseer in control of major financial decisions at the company while the underlying fraud allegations continue working through litigation.
Given the scope of the allegations, spanning prescription fraud, unauthorized use of medical credentials, and deceptive billing practices, this case is likely to remain a closely watched example of how federal regulators are approaching oversight of the broader telehealth industry, particularly companies built around high-volume, low-friction prescribing models.
FAQs
Q: If I’m a current Zealthy patient, is my prescription safe to continue using?
A: If you have concerns about how your prescription was issued or by whom, it’s worth contacting your pharmacy or a licensed physician directly to verify the prescription’s legitimacy and appropriateness for your situation, rather than assuming everything is in order based on this litigation alone.
Q: Does an asset freeze mean Zealthy has already been found guilty of fraud?
A: No. An asset freeze and receivership are precautionary legal measures meant to preserve funds during ongoing litigation. They don’t represent a final finding of liability, which would require either a settlement agreement or a court ruling on the underlying allegations.
Q: What’s the difference between this case and the earlier Cerebral settlement?
A: Cerebral, Kyle Robertson’s earlier company, settled its portion of the case relatively early, agreeing to specific consumer redress and civil penalties. Zealthy and Robertson personally have continued contesting the case, which is why the litigation against them has escalated further, including this recent push for an asset freeze.
Q: How can patients tell if a telehealth prescription was issued through a legitimate provider review?
A: Checking whether your telehealth provider is verified through an independent credentialing organization, and confirming that a licensed clinician actually reviewed your specific medical history before issuing a prescription, are reasonable steps. If you have doubts, contacting the prescribing provider’s office directly or consulting your regular pharmacy can help confirm the prescription’s legitimacy.
